Liu T - Search Results

1

A Listeria ivanovii balanced-lethal system may be a promising antigen carrier for vaccine construction.

Lei Y, Zhou Y, Zhang Y, Liu S, Tian S, Ou Q, Liu T, Huang H, Tang T, Wang C. Lei Y, et al. Among authors: liu s, liu t. Microb Biotechnol. 2022 Nov;15(11):2831-2844. doi: 10.1111/1751-7915.14137. Epub 2022 Sep 7. Microb Biotechnol. 2022. PMID: 36069650 Free PMC article.

2

Coating With Chitooligosaccharides Enhances the Cytokine Induction of Listeria ivanovii-Based Vaccine Strain.

Zhang X, Su L, Huang H, Jiang M, Liu S, Li Y, Liu T, Zhou Y, Tang T, Mahdy SE, Wang C. Zhang X, et al. Among authors: liu s, liu t. J Pharm Sci. 2019 Sep;108(9):2926-2933. doi: 10.1016/j.xphs.2019.04.011. Epub 2019 Apr 14. J Pharm Sci. 2019. PMID: 30995448

3

[Comparison of the Effects of ILO and LLO in Helping Listeria Adhere, Invade Cell and Intracellularly Multiply].

Liu SJ, Liu T, Zhou YZ, Guo N, Huang H, Wang C. Liu SJ, et al. Among authors: liu t. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 Mar;50(2):152-156. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31106531 Chinese.

4

[Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant Listeria ivanovii].

Liu T, Liu SJ, Zhou YZ, Zhang YW, Wang C. Liu T, et al. Among authors: liu sj. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 Jan;51(1):1-6. doi: 10.12182/20200160201. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 31950781 Chinese.

5

Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model.

Su L, Zhang Y, Zhang X, Liu T, Liu S, Li Y, Jiang M, Tang T, Shen H, Wang C. Su L, et al. Among authors: liu s, liu t. Sci Rep. 2021 Jun 28;11(1):13404. doi: 10.1038/s41598-021-92875-9. Sci Rep. 2021. PMID: 34183739 Free PMC article.

6

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia.

Yu W, Zhang H, Yuan Y, Tang J, Chen X, Liu T, Zhao X. Yu W, et al. Among authors: liu t. Front Cell Dev Biol. 2022 Aug 4;10:928140. doi: 10.3389/fcell.2022.928140. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35990606 Free PMC article.

7

ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5.

Yang Y, Gao Y, Huang J, Yang Z, Luo H, Wang F, Xu J, Cui Y, Ding H, Lin Z, Zhai X, Qu Y, Zhang L, Liu T, Ye L, Niu T, Zheng Y. Yang Y, et al. Among authors: liu t. JCI Insight. 2022 Oct 10;7(19):e157081. doi: 10.1172/jci.insight.157081. JCI Insight. 2022. PMID: 36040812 Free PMC article.

8

CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis.

Ren J, Lan T, Liu T, Liu Y, Shao B, Men K, Ma Y, Liang X, Wei YQ, Luo M, Wei XW. Ren J, et al. Among authors: liu y, liu t. J Immunol. 2022 May 15;208(10):2425-2435. doi: 10.4049/jimmunol.2100341. Epub 2022 Apr 18. J Immunol. 2022. PMID: 35437281 Free PMC article.

9

Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone Disease.

Cui Y, Wang F, Zhang D, Huang J, Yang Y, Xu J, Gao Y, Ding H, Qu Y, Zhang W, Liu W, Pan L, Zhang L, Liu Z, Niu T, Liu T, Zheng Y. Cui Y, et al. Among authors: liu z, liu w, liu t. J Bone Miner Res. 2022 Apr;37(4):711-723. doi: 10.1002/jbmr.4507. Epub 2022 Feb 11. J Bone Miner Res. 2022. PMID: 35064934 Free article.

10

ALCAM regulates multiple myeloma chemoresistant side population.

Wang F, Dan Z, Luo H, Huang J, Cui Y, Ding H, Xu J, Lin Z, Gao Y, Zhai X, Yang Y, Qu Y, Zhang L, Chen F, Wang Q, Wang X, Feng Y, Liu T, Yi Q, Niu T, Zheng Y. Wang F, et al. Among authors: liu t. Cell Death Dis. 2022 Feb 10;13(2):136. doi: 10.1038/s41419-022-04556-8. Cell Death Dis. 2022. PMID: 35145058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32,917 results

Search Page